NOXXON TO PRESENT CLINICAL TRIAL UPDATE AT BIO€QUITY EUROPE
Update highlights patient recruitment and effects of NOX-A12 monotherapy on the tumor microenvironment of a pancreatic tumor
Update highlights patient recruitment and effects of NOX-A12 monotherapy on the tumor microenvironment of a pancreatic tumor
JPT Peptide Technologies (JPT) announces the launch of The Human Proteome Peptide Catalog, the first and most comprehensive online resource for validated reference peptides in mass-spectrometry based proteomics.
The new repository provides fast…
Enhancers are regulatory regions of the DNA, giving rise to “long non-coding RNAs” (lncRNAs), which are known as crucial regulators of gene expression. Scientists from the Max Planck Institute for Molecular Genetics in Berlin now have shown that a…
ProBioGen AG, a premier service & technology provider for complex therapeutic glycoproteins, today announced that it has signed a second clinical immuno-oncology development and manufacturing agreement with Tizona Therapeutics, Inc., a privately held…
Take this unique opportunity to acquire Bayer as a customer
A new drug to help young patients with genetic obesity
Unisensor produces the lateral flow biosticks for its unique Extenso platform with SCIENION’s unrivalled sciFLEXARRAYER ultra-low volume dispensers
Year marked by advance of clinical strategy
First licensing agreement for lead compound lefitolimod concluded | Significant progress in studies | Company funding secured until the end of 2018 through successful capital measures